Will Alcoa's stock hit $59 after earnings beat?
Alcoa stock price target raised to $59 from $52 at J.P. Morgan Oct. 15, 2021 at 6:56 a.m. ETby Tomi Kilgore Alcoa's stock set for strong open after earnings beat, dividend initiation and new $500 million buyback program Oct. 15, 2021 at 6:20 a.m. ETby Tomi Kilgore No Headlines Available Other NewsPress Releases
Is Alcoa (AA) Stock still trading at a bargain?
Fast-paced Momentum Stock Alcoa (AA) Is Still Trading at a Bargain Jan. 20, 2022 at 8:50 a.m. ETon Zacks.com Jefferies Believes Alcoa (AA) Won’t Stop Here Jan. 20, 2022 at 8:25 a.m. ETon TipRanks.com
Is Alcon owned by Novartis?
Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun-off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%).
Why should you hold Alcon (ALC) in your portfolio?
Investors are optimistic about Alcon's (ALC) better-than-expected third-quarter results and robust performance by the Vision Care arm. Alcon (ALC) enhances contact lens experience, especially for new wearers, with the continued successful rollout of PRECISION1.
Alcon Unveils Latest Evolution of Cataract Integration and Connectivity at AAO 2021
Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio
FORT WORTH, Texas, November 08, 2021--Alcon Unveils Latest Evolution of Cataract Integration and Connectivity at AAO 2021
Lack of industrial space stalls biotech sector growth in Fort Worth
GENEVA, November 08, 2021--Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio
Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye Care
North Texas biotech firms attracted about $310 million in annual venture capital as of the first quarter of this year, representing a 376% increase over Q1 last year.
Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens
GENEVA, October 14, 2021--Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye Care
Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021
GENEVA, August 11, 2021--Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens
BIOCORP: 2022 Financial Calendar
FORT WORTH, Texas, July 22, 2021--Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021
BIOCORP Signs New Partnership Around InspairTM With H&T Presspart
ISSOIRE, France, January 05, 2022--Regulatory News: BIOCORP (Paris:ALCOR) (FR0012788065 – ALCOR / Eligible PEA‐PME), a French company specialized in the design, development, and manufacturing of innovative medical devices, presents its financial reporting schedule for 2022 (1).
Alcoa Corporation Declares Quarterly Cash Dividend
ISSOIRE, France & DÜSSELDORF, Germany & BLACKBURN, England, December 16, 2021--BIOCORP signs new partnership around Inspair (TM) with H&T Presspart
New Strong Buy Stocks for February 24th
PITTSBURGH, February 24, 2022--Alcoa Corporation (NYSE: AA) today announced that its Board of Directors has declared a quarterly cash dividend of $0.10 per share of the Company’s common stock, to be paid on March 24, 2022 to stockholders of record as of the close of business on March 8, 2022.
Are These Industrial Products Stocks Undervalued Right Now?
ASIX, AA, ACGL, RE, and TSE have been added to the Zacks Rank #1 (Strong Buy) List on February 24, 2022.
